维普中文期刊产品整合服务
6篇 您的检索式:作者名="Jeremy Millar"
    题名 作者 年代 出处 被引量
1Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy显示文摘Kelly Chipperfield Jane Fletcher Jeremy Millar Joanne Brooker Robin Smith Mark Frydenberg Sue Burney 2013Psycho‐Oncology2013,,10:1
2Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial显示文摘Bryan H Burmeister B Mark Smithers Val Gebski Lara Fitzgerald R John Simes Peter Devitt Stephen Ackland David C Gotley David Joseph Jeremy Millar John North Euan T Walpole James W Denham 2005Lancet Oncology2005,,9:1
3Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial显示文摘Bryan H Burmeister B Mark Smithers Val Gebski Lara Fitzgerald R John Simes Peter Devitt Stephen Ackland David C Gotley David Joseph Jeremy Millar John North Euan T Walpole James W Denham 2005Lancet Oncology2005,,9:1
4Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial显示文摘Bryan H Burmeister B Mark Smithers Val Gebski Lara Fitzgerald R John Simes Peter Devitt Stephen Ackland David C Gotley David Joseph Jeremy Millar John North Euan T Walpole James W Denham 2005Lancet Oncology2005,,:1
5Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial显示文摘Bryan H Burmeister B Mark Smithers Val Gebski Lara Fitzgerald R John Simes Peter Devitt Stephen Ackland David C Gotley David Joseph Jeremy Millar John North Euan T Walpole James W Denham 2005Lancet Oncology2005,,9:1
6Extent and predictors of grade upgrading and downgrading in an Australian cohort according to the new prostate cancer grade groupings显示文摘Object:To determine the extent and impact of upgrading and downgrading among men who underwent radical prostatectomy(RP)according to new grade groupings and to identify predictors of upgrading from biopsy grade Group Ⅰ and Ⅱ,and downgrading to grade Group I,in a community setting.Methods:Study participants included 2279 men with non-metastatic prostate cancer diagnosed 2006-2015 who underwent prostatectomy,from the multi-institutional South Australia Prostate Cancer Clinical Outcomes Collaborative registry.Extent of up-or down-grading was assessed by comparing biopsy and prostatectomy grade groupings.Risk of biochemical recurrence(BCR)with upgrading was assessed using multivariable competing risk regression.Binomial logistic regression was used to identify pre-treatment predictors of upgrading from grade Groups Ⅰ and Ⅱ,and risk group reclassification among men with low risk disease.Results:Upgrading occurred in 35%of cases,while downgrading occurred in 13%of cases.Sixty percent with grade Group I disease were upgraded following prostatectomy.Upgrading from grade Group I was associated with greater risk of BCR compared with concordant grading(Hazard ratio:3.1,95%confidence interval:1.7-6.0).Older age,higher prostate-specific antigen levels(PSA),fewer biopsy cores,higher number of positive cores and more recent diagnosis predicted upgrading from grade Group Ⅰ,while higher PSA and clinical stage predicted upgrading from grade Group Ⅱ.No clinical risk factors for reclassification were identified.Conclusion:Biopsy sampling errors may play an important role in upgrading from grade Group I.Improved clinical assessment of grade is needed to encourage greater uptake of active surveillance.Kerri Beckmann Michael O’Callaghan Andrew Vincent Penelope Cohen Martin Borg David Roder Sue Evans Jeremy Millar Kim Moretti 2019Asian Journal of Urology2019,6,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费